Weekly Poll#4: The cost of capital for early‐stage Biotech (cash multiples realised)

This is the fourth of 4 weekly Polls hosted throughout July that will accompany the August edition of Drugs&Dealers Magazine ‘Lost in Translation: Tech Transfer and Start-up Capital’.

This poll reviews the cash multiples realised by bioscience investors on their most recent investments.

The results from this Poll will be published exclusively within the weekly Subscriber newsletter and analysed within the August issue of Drugs&Dealers. Thanks for voting.


If you are interested in learning what options are open to biotechs and spin outs in terms of early stage and follow-on funding, plus how these are viewed by the community as a whole, you should consider attending our ‘Biotechs and the City - Tech Transfer and Start-up Capital’ evening panel and networking reception on the 4th September.

Tags :

Leave a comment